{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:53Z","timestamp":1786998473302,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA039928"],"award-info":[{"award-number":["R01 DA039928"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ypmed.2022.107116","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T01:55:08Z","timestamp":1655776508000},"page":"107116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Characteristics of statewide prescription drug monitoring programs and potentially inappropriate opioid prescribing to patients with non-cancer chronic pain: A machine learning application"],"prefix":"10.1016","volume":"161","author":[{"given":"Hsien-Chang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Han","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosali","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Buu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2022.107116_bb0005","series-title":"Paper presented at the International Conference on Universal Access in Human-Computer Interaction","article-title":"A pilot study: Integrating an emergency department with Indiana\u2019s prescription drug monitoring program","author":"Abedtash","year":"2013"},{"key":"10.1016\/j.ypmed.2022.107116_bb0010","series-title":"Paper presented at the Proceedings of the 2018 ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics","article-title":"Interpretable machine learning in healthcare","author":"Ahmad","year":"2018"},{"issue":"12","key":"10.1016\/j.ypmed.2022.107116_bb0015","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/MLR.0000000000001643","article-title":"An interrupted time-series evaluation of the association between state Laws mandating prescriber use of prescription drug monitoring programs and discontinuation of chronic opioid therapy in US veterans","volume":"59","author":"Arnold","year":"2021","journal-title":"Med. Care"},{"issue":"10","key":"10.1016\/j.ypmed.2022.107116_bb0020","doi-asserted-by":"crossref","first-page":"e1914051","DOI":"10.1001\/jamanetworkopen.2019.14051","article-title":"Trends and focus of machine learning applications for Health Research","volume":"2","author":"Beaulieu-Jones","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ypmed.2022.107116_bb0025","series-title":"Connecting EMRs with Washington\u2019s PDMP: Benefits of Integration","author":"Benson-Tilsen","year":"2019"},{"key":"10.1016\/j.ypmed.2022.107116_bb0030","series-title":"Institute for Pharmaceutical Outcomes and Policy, Department of Pharmacy Practice and Science, College of Pharmacy","first-page":"1","article-title":"Review of prescription drug monitoring programs in the United States","author":"Blumenschein","year":"2010"},{"issue":"13","key":"10.1016\/j.ypmed.2022.107116_bb0035","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ypmed.2022.107116_bb0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MLR.0000000000000505","article-title":"A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain","volume":"54","author":"Bohnert","year":"2016","journal-title":"Med. Care"},{"issue":"2","key":"10.1016\/j.ypmed.2022.107116_bb0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/003335491412900207","article-title":"Prescription drug monitoring and dispensing of prescription opioids","volume":"129","author":"Brady","year":"2014","journal-title":"Public Health Rep."},{"key":"10.1016\/j.ypmed.2022.107116_bb0050","author":"Centers for Disease Control and Prevention"},{"issue":"1","key":"10.1016\/j.ypmed.2022.107116_bb0055","first-page":"85","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med."},{"issue":"10","key":"10.1016\/j.ypmed.2022.107116_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/MLR.0b013e3182a95d86","article-title":"Ambulatory diagnosis and treatment of non-malignant pain in the United States, 2000\u20132010","volume":"51","author":"Daubresse","year":"2013","journal-title":"Med. Care"},{"key":"10.1016\/j.ypmed.2022.107116_bb0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2015.02.010","article-title":"Abrupt decline in oxycodone-caused mortality after implementation of Florida\u2019s prescription drug monitoring program","volume":"150","author":"Delcher","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"15","key":"10.1016\/j.ypmed.2022.107116_bb0070","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ypmed.2022.107116_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose: a cohort study","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.ypmed.2022.107116_bb0080","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jpainsymman.2010.01.012","article-title":"An analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP study","volume":"40","author":"Edlund","year":"2010","journal-title":"J. Pain Symptom Manag."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107116_bb0085","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12913-017-2354-5","article-title":"Evaluating the impact of prescription drug monitoring program implementation: a scoping review","volume":"17","author":"Finley","year":"2017","journal-title":"BMC Health Serv. Res."},{"issue":"4","key":"10.1016\/j.ypmed.2022.107116_bb0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s13181-012-0273-8","article-title":"Windmills and Pill Mills: can PDMPs tilt the prescription drug epidemic?","volume":"8","author":"Gugelmann","year":"2012","journal-title":"J. Med. Toxicol."},{"issue":"5","key":"10.1016\/j.ypmed.2022.107116_bb0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.amepre.2019.06.007","article-title":"An examination of concurrent opioid and benzodiazepine prescribing in 9 states, 2015","volume":"57","author":"Guy","year":"2019","journal-title":"Am. J. Prev. Med."},{"issue":"8","key":"10.1016\/j.ypmed.2022.107116_bb0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMp1904714","article-title":"Prescription drug monitoring programs\u2014friend or folly in addressing the opioid-overdose crisis?","volume":"381","author":"Haffajee","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.ypmed.2022.107116_bb0105","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.2020.18543","article-title":"The opioid epidemic during the COVID-19 pandemic","volume":"324","author":"Haley","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2022.107116_bb0110","series-title":"Drug Overdose Deaths in the United States, 1999\u20132018","author":"Hedegaard","year":"2020"},{"issue":"10","key":"10.1016\/j.ypmed.2022.107116_bb0115","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1080\/10826084.2017.1416407","article-title":"High-risk prescribing to Medicaid enrollees receiving opioid analgesics: individual-and county-level factors","volume":"53","author":"Heins","year":"2018","journal-title":"Subst. Use Misuse"},{"issue":"1","key":"10.1016\/j.ypmed.2022.107116_bb0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jat\/34.1.32","article-title":"Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites","volume":"34","author":"Heltsley","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.ypmed.2022.107116_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106861","article-title":"Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015\u20132018","volume":"153","author":"Henry","year":"2021","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2022.107116_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pmedr.2017.12.010","article-title":"Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993\u20132014","volume":"9","author":"Hirschtritt","year":"2018","journal-title":"Prev. Med. Rep."},{"issue":"2","key":"10.1016\/j.ypmed.2022.107116_bb0135","first-page":"1","article-title":"A review on evaluation metrics for data classification evaluations","volume":"5","author":"Hossin","year":"2015","journal-title":"Int. J. Data Min. Knowledge Manag. Proc."},{"issue":"4","key":"10.1016\/j.ypmed.2022.107116_bb0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am. J. Prev. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107116_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40122-018-0097-6","article-title":"A brief history of the opioid epidemic and strategies for pain medicine","volume":"7","author":"Jones","year":"2018","journal-title":"Pain Ther."},{"key":"10.1016\/j.ypmed.2022.107116_bb0150","series-title":"British Medical Journal Publishing Group","article-title":"The growing problem of co-treatment with opioids and benzodiazepines","author":"Karaca-Mandic","year":"2017"},{"key":"10.1016\/j.ypmed.2022.107116_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.04.029","article-title":"Past-year use of prescription opioids and\/or benzodiazepines among adults in the United States: estimating medical and nonmedical use in 2015\u20132016","volume":"204","author":"Li","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2022.107116_bb0160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.addbeh.2017.08.032","article-title":"Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain","volume":"76","author":"Lin","year":"2018","journal-title":"Addict. Behav."},{"key":"10.1016\/j.ypmed.2022.107116_bb0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ypmed.2018.10.011","article-title":"Interstate data sharing of prescription drug monitoring programs and associated opioid prescriptions among patients with non-cancer chronic pain","volume":"118","author":"Lin","year":"2019","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2022.107116_bib226","series-title":"Advances in Neural Information Processing Systems","first-page":"4765","article-title":"A unified approach to interpreting model predictions","author":"Lundberg","year":"2017"},{"issue":"9","key":"10.1016\/j.ypmed.2022.107116_bb0175","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.ypmed.2022.107116_bb0180","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s11606-011-1771-0","article-title":"Long-term chronic opioid therapy discontinuation rates from the TROUP study","volume":"26","author":"Martin","year":"2011","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.ypmed.2022.107116_bb0185","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/EDE.0000000000001404","article-title":"Prescription opioid laws and opioid dispensing in US counties: identifying salient law provisions with machine learning","volume":"32","author":"Martins","year":"2021","journal-title":"Epidemiology"},{"issue":"Oct","key":"10.1016\/j.ypmed.2022.107116_bb0190","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"issue":"8","key":"10.1016\/j.ypmed.2022.107116_bb0195","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s11606-018-4374-1","article-title":"Physicians' perspectives regarding prescription drug monitoring program use within the Department of Veterans Affairs: a multi-state qualitative study","volume":"33","author":"Radomski","year":"2018","journal-title":"J. Gen. Intern. Med."},{"issue":"1\u20132","key":"10.1016\/j.ypmed.2022.107116_bb0200","first-page":"77","article-title":"Prescription monitoring programs: striking the balance between medical use and diversion","volume":"22","author":"Simoni-Wastila","year":"2011","journal-title":"J. Addict. Nurs."},{"key":"10.1016\/j.ypmed.2022.107116_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2019.02.010","article-title":"Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing","volume":"199","author":"Strickler","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2022.107116_bib227","series-title":"Machine Learning for Healthcare Conference","first-page":"359","article-title":"What clinicians want: contextualizing explainable machine learning for clinical end use","author":"Tonekaboni","year":"2019"},{"key":"10.1016\/j.ypmed.2022.107116_bb0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugalcdep.2018.03.036","article-title":"Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing","volume":"188","author":"Winstanley","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.ypmed.2022.107116_bb0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/01612840.2011.654046","article-title":"Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research","volume":"33","author":"Worley","year":"2012","journal-title":"Issues Mental Health Nurs."},{"issue":"11","key":"10.1016\/j.ypmed.2022.107116_bb0225","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/pme.12480","article-title":"Risk factors for serious prescription opioid-related toxicity or overdose among veterans health administration patients","volume":"15","author":"Zedler","year":"2014","journal-title":"Pain Med."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522001657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522001657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:15:57Z","timestamp":1758795357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743522001657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":45,"alternative-id":["S0091743522001657"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107116","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of statewide prescription drug monitoring programs and potentially inappropriate opioid prescribing to patients with non-cancer chronic pain: A machine learning application","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107116"}}